Abstract
Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 1151-1155 |
| Number of pages | 5 |
| Journal | Orvosi Hetilap |
| Volume | 154 |
| Issue number | 29 |
| DOIs | |
| Publication status | Published - júl. 1 2013 |
Fingerprint
Keywords
- boceprevir
- cirrhosis
- direct acting antiviral agents
- direkt ható antivirális szerek
- hepatitis C
- hepatitis C virus
- kezelési prioritás
- priority of treatment
- registry
- telaprevir
ASJC Scopus subject areas
- Medicine(all)
Cite this
A krónikus vírushepatitisek hazai ellátási rendszerének sajátosságai : Hepatitis Regiszter és a Prioritási Index. / Makara, Mihály; Horváth, Gábor; Szalay, F.; Tornai, István; Hunyady, B.
In: Orvosi Hetilap, Vol. 154, No. 29, 01.07.2013, p. 1151-1155.Research output: Article
}
TY - JOUR
T1 - A krónikus vírushepatitisek hazai ellátási rendszerének sajátosságai
T2 - Hepatitis Regiszter és a Prioritási Index
AU - Makara, Mihály
AU - Horváth, Gábor
AU - Szalay, F.
AU - Tornai, István
AU - Hunyady, B.
PY - 2013/7/1
Y1 - 2013/7/1
N2 - Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.
AB - Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.
KW - boceprevir
KW - cirrhosis
KW - direct acting antiviral agents
KW - direkt ható antivirális szerek
KW - hepatitis C
KW - hepatitis C virus
KW - kezelési prioritás
KW - priority of treatment
KW - registry
KW - telaprevir
UR - http://www.scopus.com/inward/record.url?scp=84880438009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880438009&partnerID=8YFLogxK
U2 - 10.1556/OH.2013.29671
DO - 10.1556/OH.2013.29671
M3 - Article
C2 - 23853348
AN - SCOPUS:84880438009
VL - 154
SP - 1151
EP - 1155
JO - Orvosi Hetilap
JF - Orvosi Hetilap
SN - 0030-6002
IS - 29
ER -